Yes, some numbers.
And I'm going to start with the order intake as we normally do, which you saw was very pleasing. We did just about 1.1 billion Swedish crowns in order intake, reflecting 19% growth or 10% organic growth. And you see, we also have 10% organic growth for the last 12 months. And Staffan touched upon it already.
One very big contributing factor to the strong order intake was the Molex acquisition. And the fact that we got many of these full year orders.
So we were very pleased with the underlying business as well.
And, in that number of 1.1 billion, we do think we have around 130 million where customers have been placing orders that they normally would maybe do throughout the year, but now placing everything in Q1, and underlying, we can see it's really all divisions and all geographic markets that are doing well. So we see a broad-based strong demand. And, with everything happening in the world, we were quite happy to see that the customers still investing and placing orders. And maybe what sticks out the most for us is the INT division. I'll come back to that with the organic growth of 25%.
And we've been talking about this for maybe some 12, 18 months that we thought we would see this pick up, and now we're maybe a bit later than what we believed. And now we're seeing that business coming back on a really broad base.
Also now in Q1, if we move over to the sales side, we begin.
We are also continuing the growth in sales. Do you see on the graph there?
It's a nice continued development, with Net sales of 971 million and a 9% growth, which is actually 15% organically. And now it's the second quarter where we have double-digit organic growth. And if you've been following us, you've been seeing that we had a more challenging situation throughout 2024 and first half of 25.
And now we feel that we're back on the right track with inventory levels normalizing in the supply chains. Also very good to note that we do have a book-to-bill of 1.16. We've been saying that we believe we should have more than one this year to continue the growth journey and to place the foundation for future growth. So the 1.16 book-to-bill is a very good number, especially when we show this 15% organic growth on sales. What's behind also here is quite broad-based. We see our four largest markets are among the ones that are performing the best.
So, in order of size, we have the US, and our biggest markets are Germany, Japan, and China. All of them are contributing very well to this development. And then going into the divisions, we're starting with Industrial Data Solutions, the largest one. And now it represents 40% of the group's profits.
And here you see on the order intake that we report -3% in development; organically, that's +5% due to the massive currency effects from Q1 2025 until now.
As you might remember, after Q1, I think it was in April, the especially the US dollar took a big hit versus the Swedish crown. And that is a big impact on the bridge. Of course, when you compare quarter to quarter net sales, a good number, the Q4 number for 2025 was exceptionally strong in the 481, now 418, as we do in the quarter for us is not bad, a 13% organic growth. And I think this also comes down to good margins of 25.4%.
So we've been able to build the margin in this division quite well from around 20% to 25%. If you take an 18-month period, and here North America is the biggest market. That's also what is performing the best. It's a little bit slower for us in IDs in Europe and APAC still. Okay. And to mention one big driver, we've been seeing the data center vertical performing very well, winning new business in various applications for data center business. And just to mention, we are also, on the other hand, facing a very tough comp in Q1 2025. So both in Q4 24 and Q1 25, we had some big product orders that we did not really have now in the beginning of 2026. So we see a strong underlying development.
Then over to Industrial Network Technology, a fantastic quarter with a 25% organic growth in orders and 23% growth on net sales.
And here you also see on the green bar in the left-hand side graph, the Molex business coming in with 140 MSEK. So the reported growth is now 73%, very strong. Add-on to the business.
Of course, this order intake pace is not sustainable.
And I think Staffan said it. That is basically our customers placing orders for the full year. So I think that what you can expect is maybe more the pace that you see on the sales run rate of 40 million on a quarterly level. And Staffan also mentioned this has been turning out a bit better than we expected. We didn't know exactly what to expect, given that it was some older products and some customers that have been announced with end of life. Integration is going well, and we find it difficult to pick out many markets that are performing well or poorly.
Integration is going well, and we find it difficult to identify many markets that are performing well or poorly.
We see there are very key markets in Central Europe and Japan is driving that, that is, those are really big markets for INT. So that's very good to see that we are back to good growth in those key markets. And then finally, New Industries also had a solid quarter. We have a 7% organic growth on orders and 8% on net sales.
So pretty much in line with our financial long-term targets and also good profitability with over 27% EBITDA margin.
And here we saw a good development in the Vehicle Communication business, both in Europe and North America. On the building automation business, we had a good start. The first two months were quite good. And then in March we saw a massive slowdown in orders from the Middle East, which has been impacting the numbers a little bit.
And again, for the group, this is not a big impact. It's less than 2% in the Middle East of the total sales. But for building automation, it's 20% of the business. So, such a significant slowdown is, of course, visible for that part of the business.
And then going over to the results. And first, I just want to make you aware that we are now reporting a new main profitability metric, EBITDA, which was 264 MSEK with a 27% margin. So this is our long term operating target for profitability. And this is where we have the target to reach 25% EBITDA. And the difference compared to before when we showed adjusted EBIT is actually a bit more difficult for us as a company to live up to.
It's the same in that we are removing the amortization of excess values, but we're not making any other adjustments. So all the integration costs, M&A costs, this is actually burdening the EBITDA results.
Also, amortization of activated R&D cost is impacting the number. I hope that was clear how that works.
Otherwise you have to ask, and what we can see then is 264 MSEK with a 27% margin, a very strong start to the year for us. And good to see that we are above the financial target is really a strong top line and cost control that is behind the number. So nothing strange.
Looking at the gross margin, we were slightly down compared to last year. A big negative effect from currency. And also, I would say it's a good product mix within the divisions. But the fact that INT is growing a lot and taking a bigger share of the whole is reducing the group margin a little bit. And I think we've been talking about this before, that when and if INT starts to come back to good old form, that will put a bit of a pressure on the margin.
On the other side, we have been really successful with the price increases, and the volume is good in the quarter, which is mitigating. And all in all, with the mix that we have, we're quite happy to be able to present 62.4 on the OpEx side, we came in a little bit short of what we believed we would do. It's, we're a little bit behind on some of the plans.
We are investing in certain areas of the business, both in R&D, also adding a team in artificial intelligence to drive that development within the group, and it's a little bit behind schedule, but we will be there and recoup. And then we also have salary increases coming in Q2. So looking ahead, we will have a little bit of a higher cost level.
Yes. Two more things I want to mention here. One is the R&D, where we are, as Staffan also said, now investing in both INT and IDS in the new generation of products, which is increasing the pace of investment in R&D and activation of cost. And this increased to 27 million from 15 last Q1. And so 12 million more in activated R&D, which of course, you could say a little bit helps the results. On the other hand, you see the FX effect, as we had some really good currency hedges in 2025, which have been wearing off towards the end of the year and now into 2026. We still have hedges, but at lower rates than what we used to have before. And so we see a pretty big impact on EBIT, EBITDA of 31 million. 30. 31 million from the FX rates.
If we move on further down in the profit and loss, we come to the adjusted results, adjusted EPS results. And here we have a 3.78 adjusted EPS.
A pretty solid number. We're happy to see interest cost coming down from 34 million a year ago to 20 now.
It's a combination of, of course, reduced debt, but also better terms in the financing agreement, which is keeping that down a little bit.
And, if you want to see the reported EPS, we're at 3.24. And here we are just adjusting for the excess value's amortization of the acquisitions. We continue to show a good cash conversion. And the cash flow is solid with 250 MSEK. And behind that, we're reducing inventories a little bit in Q1, but we're tying up quite a bit more in accounts receivable due to strong invoicing at the end of the quarter. March was a very strong month in invoicing. So we tie up some 37 million more in working capital in Q1.
And for the year, Staffan mentioned already, 940 million on good track to that billion mark that we would really like to reach soon. And then if we look at the net debt situation, it continues to move in the right pattern; we are reducing it a bit more since Q4 and are now down on net debt.
EBITDA, if I look at a pre-IFRS 16 basis of 1.87, and of course that puts us in a good, good spot compared to 3.36 a year ago. And we're quite happy with that reduction. And it also means that we can put some more efforts into the M&A agenda again. And we are building that agenda now in the divisions, and it's going quite well in looking at new targets and building that pipeline.
So just to summarize before we hand over for questions, takeaways from the first quarter. What we would like you to remember is a solid order intake of over 1 billion for the first time for us, organic growth in sales of 15% for the second quarter in a row, with double-digit growth on the net sales side. And then we also would like to be clear with these pre-orders of about 130 million that you cannot expect to come back in coming quarters. And then INT, we need to highlight INT's very strong development here with both over 20% organic growth in both orders and sales and a good start to the new acquisition in INT, and the macro situation still uncertain.
We are happy to see that the underlying market seems to be working well enough anyway.
And Middle East, even if it's a bit of an impact on the Building Automation business, not a lot. Building Automation business, not a lot for the whole group. And what we also do see, I'm not sure if we talked about this before, we do see lead times for certain semiconductors coming up again, for instance, memories, and also some prices coming up a bit. We are not impacted by the worst latest geometries. But still, it's a bit of a push upwards in pricing. And we are trying to now place orders for more or less the full year to make sure that we have the material we need to be able to continue to deliver.
And finally, profitability and cash flow performed quite well. Both cash flow and cash conversion are good, and underlying profitability is slightly better than our long-term targets. And we are continuing to invest in the business now in R&D in AI. And we are very happy to see the continued development.
With that, I would like to hand over to the operator for. For questions.